IP Library Granted Patent US 12,465,075
Granted Patent B2
US 12,465,075 · App. 17/784,315 · Granted Nov 11, 2025

Particles containing a lipid matrix core and active ingredient

Inventors: Tyler White (Greenwood, SC); Christopher Craig (Greenwood, SC); David Vodak (Greenwood, SC); Shane Durkee (Greenwood, SC)
Assignee: Lonza Sales AG
A23P10/35A23L33/105A23L33/155A61K9/4858A61K9/5047A61K9/5073A61K9/5089A61K31/01A61K31/07A61K31/122
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,465,075
App. No.
17/784,315
Granted
Nov 11, 2025
Kind
B2
Abstract

A composition containing a plurality of particles containing a core having a lipid matrix including an active ingredient dispersed therein is disclosed. The active ingredient can include a fat-soluble active ingredient. The particles can be contained in a capsule. Also provided are methods for producing a pharmaceutical composition containing a plurality of particles containing a core having a lipid matrix including an active ingredient dispersed therein.

Claims (13)

1 . A composition comprising:

a plurality of particles, wherein each of the plurality of particles comprises a core having a lipid matrix with an active ingredient dispersed therein, wherein the active ingredient comprises a fat-soluble active ingredient and at least one outer layer disposed on the core, wherein the fat-soluble active ingredient comprises one or more carotenoids and wherein the at least one outer layer comprises at least one second active ingredient layer.

2 . The composition of claim 1 , wherein the active ingredient comprises from about 10% to about 60% by weight of the core.

3 . The composition of claim 1 , wherein the one or more carotenoids are selected from the group consisting of lutein, astaxanthin, zeaxanthin, alpha-carotene, beta-carotene, cryptoxanthin, lycopene, and mixtures thereof.

4 . The composition of claim 1 , wherein the core is solid at ambient temperature.

5 . The composition of claim 1 , wherein the core has a mean diameter ranging from about 40 μm to about 3000 μm.

6 . The composition of claim 1 , wherein the lipid matrix comprises at least one low flow point excipient and at least one high flow point excipient.

7 . The composition claim 1 , wherein the at least one outer layer comprises one or more adhesives and one or more active ingredients.

8 . The composition of claim 1 , wherein the at least one second active ingredient comprises one or more fat-soluble vitamins or minerals, one or more water soluble vitamins or minerals, and combinations thereof.

9 . The composition of claim 1 , wherein the core comprises about 5% to about 60% by weight of the plurality of particles.

10 . The composition of claim 1 , wherein the one or more particles comprise an average diameter of from about 0.5 mm to about 1.5 mm.

11 . The composition of claim 1 , further comprising an outermost layer comprised of a coating material for sealing each of the plurality of particles.

12 . The composition of claim 1 , wherein the plurality of particles further contain one or more adjuvants chosen from anti-adherents, binders, coatings, colors, disintegrants, fillers, flavoring agents, glidants, lubricants, preservatives, sorbents, sweeteners, vehicles, vitamins, and the like.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2025
From: CAPSUGEL BELIUM NV
To: LONZA SALES AG
Reel/Frame 071121/0470 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2022
From: WHITE, TYLER; CRAIG, CHRISTOPHER; VODAK, DAVID; DURKEE, SHANE
To: CAPSUGEL BELGIUM NV
Reel/Frame 060165/0574 →
Continuity (2)
Provisional Application 62946107 · Dec 10, 2019
Related Publication 20220361552A1 · Nov 17, 2022
References Cited (13)
US 5705196A · Galan et al. · 1998 [cited by applicant]
US 5731006A · Akiyama et al. · 1998 [cited by applicant]
US 6887493B2 · Shefer et al. · 2005 [cited by applicant]
US 10512650B2 · Niichel · 2019 [cited by applicant]
US 11504330B2 · Vetter et al. · 2022 [cited by applicant]
US 20030148992A1 · Block et al. · 2003 [cited by applicant]
US 20070128272A1 · Zerbe · 2007 [cited by examiner]
US 20100068276A1 · Friesen et al. · 2010 [cited by applicant]
US 20150328158A1 · Deshpande et al. · 2015 [cited by applicant]
JP 2012035167 · 2012 [cited by applicant]
WO WO9420072 · 1994 [cited by applicant]
WO WO2015173603A1 · 2015 [cited by examiner]
International Search Report and Written Opinion for PCT/US2020/064237 dated Mar. 29, 2021, 11 pages. [cited by applicant]